Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO)
...ve patients (18%) had a glufosfamide-related serious adverse event (SAE),
which included renal tubular acidosis (RTA) with renal failure (2
patients),
rta alone, vomiting or nausea. Three patients died from an SAE
unrelated to glufosfamide. Another patient developed an SAE of renal
failure after hypotens...
Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer
...sity of Texas M.D. Anderson Cancer
Center in 2004.
rta 402, the lead agent from this series, has
recently...e 1 study in cancer
patients has demonstrated that
rta 402 has potent single-agent
anti-cancer activity i... has recently been confirmed in
a Phase 1 study of
rta 402 in cancer patients being conducted at
the M.D....
RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds
Significant Promise for Treating Breast Cancer
...cer Center.
The authors conducted two studies of
rta 402 in the highly
rigorous 4T1 mouse model of brea... body. In two separate experiments, treatment with
rta 402 was
found to have a profound effect in suppres... model mimicking the spread of
metastatic disease,
rta 402 completely blocked the development of
metastas...
RTA 402 Shown to Protect Animals Against Toxicities of Standard
Cancer Treatments
...lead anti-cancer agent, the
Synthetic Triterpenoid
rta 402, is effective at protecting against
common tox...and collaborators presented data showing that
when
rta 402 is given in combination with radiation therapy...ol, a well-known expert on cancer supportive care.
rta 402 is a
novel, orally administered targeted thera...